• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cutaneous reactions following subcutaneous beta-interferon-1b injection.

作者信息

Ohata Utako, Hara Hiroyuki, Yoshitake Mari, Terui Tadashi

出版信息

J Dermatol. 2010 Feb;37(2):179-81. doi: 10.1111/j.1346-8138.2009.00783.x.

DOI:10.1111/j.1346-8138.2009.00783.x
PMID:20175855
Abstract
摘要

相似文献

1
Cutaneous reactions following subcutaneous beta-interferon-1b injection.
J Dermatol. 2010 Feb;37(2):179-81. doi: 10.1111/j.1346-8138.2009.00783.x.
2
Dermal fibrosis and cutaneous necrosis after recombinant interferon-beta1a injection in a multiple sclerosis patient.一名多发性硬化症患者注射重组β-1a干扰素后出现皮肤纤维化和皮肤坏死。
J Eur Acad Dermatol Venereol. 2005 Jan;19(1):112-3. doi: 10.1111/j.1468-3083.2004.01086.x.
3
[Livedo reticularis following subcutaneous injection of interferon beta-1b].
Rev Neurol. 2010 Jul 1;51(1):62.
4
Recurrent injection site reactions from interferon beta 1-b.β-1b干扰素引起的反复注射部位反应
J Drugs Dermatol. 2006 Apr;5(4):366-7.
5
Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b.复发缓解型多发性硬化症患者接受β-1a或β-1b干扰素治疗时注射部位疼痛及注射部位反应的比较
Mult Scler. 2007 Nov;13(9):1153-60. doi: 10.1177/1352458507079291.
6
Severe local skin reactions to interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection.多发性硬化症患者中干扰素β-1b的严重局部皮肤反应——通过皮下深层注射改善
Eur J Dermatol. 2008 Sep-Oct;18(5):579-82. doi: 10.1684/ejd.2008.0494. Epub 2008 Aug 8.
7
Vitamin K cream reduces reactions at the injection site in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon beta - VIKING study.
Mult Scler. 2015 Aug;21(9):1215-6. doi: 10.1177/1352458514562989. Epub 2015 Feb 6.
8
Widespread maculopapular rash due to intramuscular interferon beta-1a during the treatment of multiple sclerosis.多发性硬化症治疗期间因肌内注射干扰素β-1a出现广泛的斑丘疹。
Mult Scler. 2008 Mar;14(2):259-61. doi: 10.1177/1352458507079945.
9
Cutaneous ulcerations following subcutaneous interferon beta injection to a patient with multiple sclerosis.一名多发性硬化症患者皮下注射β-干扰素后出现皮肤溃疡。
J Dermatol. 2004 Aug;31(8):671-7. doi: 10.1111/j.1346-8138.2004.tb00575.x.
10
Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.复发缓解型多发性硬化症患者接受干扰素β-1b 250微克和500微克隔日治疗12至28周的耐受性和安全性概况：一项多中心、随机、双盲、平行组试点研究。
Clin Ther. 2008 Jun;30(6):1102-12. doi: 10.1016/j.clinthera.2008.06.013.

引用本文的文献

1
Cutaneous Adverse Effects of Neurologic Medications.神经科药物的皮肤不良反应
CNS Drugs. 2016 Mar;30(3):245-67. doi: 10.1007/s40263-016-0318-7.
2
Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis.与干扰素-β治疗多发性硬化症相关的皮肤不良事件
Int J Mol Sci. 2015 Jul 2;16(7):14951-60. doi: 10.3390/ijms160714951.